TFEB and metabolic dysfunction-associated steatotic liver disease: This is substantiated by studies demonstrating that TFEB inhibition abolishes lipophagy and makes for the decomposition of cellular lipid in anti-non-alcoholic fatty liver disease (Wang et al., 2019).